Requests that the FDA Change its Interpretation that a Company Name is Confidential Commercial Information or Allow Disclosure of the Name of a Company Linked to a Foodborne Illness Outbreak Even When There is no Related Recall | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-1448

Requests that the FDA Change its Interpretation that a Company Name is Confidential Commercial Information or Allow Disclosure of the Name of a Company Linked to a Foodborne Illness Outbreak Even When There is no Related Recall

Documents

Comments

Description

Open

Key Dates

Comment Period OpensFeb 9, 2026

Documents

Type	Title	Posted	Comments	Status
Other	180 Day Interim Response Letter from FDA HFP to Stop Foodborne Illness	Jul 29, 2026	--

Keywords

HFP

Citizen Petition

Stop Foodborne Illness

Requests that the FDA change its position that a

company name is CCI. This action can be easily

achieved through an agency statement or

memorandum announcing a change in its

interpretation of the Trade Secrets Act

Data from Regulations.gov